US Medical Marijuana Business News
Nearly two dozen state attorneys general from across the U.S. signed a letter to congressional leaders this week urging lawmakers to crack down on marijuana edibles brands that imitate popular mainstream candies.
The SAFE Banking Act has hit yet another wall in Congress and won’t be included in the final version of an economic stimulus bill.
A wing of the U.S. Treasury Department is planning to gather data from banks on marijuana businesses as part of its money-laundering risk oversight.
Legal and lightly taxed, CBD operators have enormous business advantages compared to their colleagues growing and selling high-THC cannabis and its extracts.
But how will they fit in the overall cannabis industry when all THC levels – think recreational marijuana – are legal?
Global supply-chain woes – first triggered by the coronavirus pandemic in 2020 – have been exacerbated by Russia’s invasion of Ukraine, and the U.S. cannabis industry is expected to feel the added fallout for months.
Republican U.S. Rep. Nancy Mace discusses the prospects of Congress passing her marijuana reform bill, the States Reform Act.
The U.S. Senate gave unanimous approval to a bipartisan bill to “cut the red tape” that stalls scientific research into the medical properties of cannabis and cannabidiols.
